The laboratory approach to the diagnosis of autoimmune diseases: Is it time to change?

Autoimmunity Reviews

Volumn 6, Issue 6, 2007, Pages 359-365

  Villalta, Danilo ^a   Tozzoli, Renato ^b   Tonutti, Elio ^c   Bizzaro, Nicola ^b  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b Ospedale Civile   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Appropriateness; Autoantibodies; Autoimmune diseases; Microarrays; Proteomics

Indexed keywords

AUTOANTIBODY;

ALGORITHM; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; CLINICAL LABORATORY; DIAGNOSTIC APPROACH ROUTE; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL TECHNIQUE; LABORATORY DIAGNOSIS; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; PRACTICE GUIDELINE; PROGNOSIS; PROTEOMICS; REVIEW; RISK ASSESSMENT; STANDARD; VALIDATION PROCESS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; FALSE POSITIVE REACTIONS; HUMANS; PRACTICE GUIDELINES; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

EID: 34249721444     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.01.009     Document Type: Review

References (37)

1. van Mühlen C.A., and Tan E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24 (1995) 333-358
2. Tan E.M., Chohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
3. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725-1734
4. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36 (1993) 340-347
5. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. Internationl consensus statement on an update of the preliminary classification criteria for antiphodpholipid syndrome (APS). J Thromb Haemost 3 (2005) 1-12
6. Bootsma H., Spronk P., Derksen R., de Boer G., Wotters-Dicke H., Hermans J., et al. Prevention of relapse systemic lupus erythematosus. Lancet 345 (1995) 1595-1599
7. Tervaert J.W., Huitema M.G., Hene R.J., Sluiter W.J., The T.H., van der Hem G.K., et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336 (1990) 709-711
8. Scofield R.H. Autoantibodies as predictor of disease. Lancet 383 (2004) 1544-1546
9. Gonzales-Buitrago J.M., and Gonzales C. Present and future of the autoimmunity laboratory. Clin Chim Acta 365 (2006) 50-57
10. College of American Pathologists. Standard for laboratory accreditation (1996), College of Amarican Pathologists, Northfield (IL)
11. Price C.P. Application of the priciples of evidence-based medicine to laboratory medicine. Clin Chim Acta 333 (2003) 147-154
12. American College of Rheumathology ad hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Care Res 47 (2002) 429-433
13. Tozzoli R., Bizzaro N., Tonutti E., Villalta D., Bassetti D., Manoni F., et al. Guidelines for laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117 (2002) 316-324
14. James S. National Institutes of Health consensus developement conference statement on celiac disease. Jan 28-30, 2004. Gastroenterology 128 suppl 1 (2005) S1-S9
15. Savige J., Gillis D., Benson E., Davies D., Esnault V., Falk R.J., et al. International Consensus Statement on Testing and Reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111 (1999) 507-513
16. Plebani M. Appropriateness in programs for continuous quality improvement in clinical laboratories. Clin Chim Acta 333 (2003) 131-139
17. Wiik A.S. Appropriateness of autoantibody testing in clinical medicine. Clin Chim Acta 333 (2003) 177-180
18. Bizzaro N., and Wiik A. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 22 (2004) 349-355
19. Fathman C.G., Soares L., Chan S.M., and Utz P.J. An array possibilities for the study of autoimmunity. Nature 435 (2005) 605-611
20. Geysen H.M., Meloen R.H., and Barteling S.J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A 81 (1984) 3998-4002
21. Canelle L., Bousquet J., Pionneau C., Deneux L., Imam-Sghiouar N., Caron M., et al. An efficient proteomics-based approach for the screening of autoantibodies. J Immunol Methods 299 (2005) 77-89
22. Liao H., Wu J., Kuhn E., Chin W., Chang B., Jones M.D., et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50 (2004) 3792-3803
23. Drynda S., Ringel B., Kekow M., Kuhne C., Drynda A., Glocker M.O., et al. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol Res Pract 200 (2004) 165-171
24. Stone J.H., Rajapakse V.N., Hoffman G.S., Specks U., Merkel P.A., Spiera R.F., et al. A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis. Arthritis Rheum 52 (2005) 902-910
25. Joos T., Schrenk M., Höpfl P., Kroger K., Chowdhury U., Stoll D., et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 21 (2000) 2641-2650
26. Robinson W.H., DiGennaro C., Hueber W., Haan B.B., Kamachi M., Dean E.J., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8 (2002) 295-301
27. Feng Y., Ke X., Ma R., Chen Y., Hu G., and Liu F. Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clin Chem 50 (2004) 416-422
28. Hueber W., Kidd B.A., Tomooka B.H., Lee B.J., Bruce B., Fries J.F., et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 52 (2005) 2645-2655
29. Quintana F.J., Hagedom P.H., Elizur G., Merbl Y., Domany E., and Cohen I.R. Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci 101 (2004) 14615-14621
30. Wang X., Yu J., Sreekumar A., Varambally S., Shen R., Giacherio D., et al. Autoantibody signatures in prostate cancer. N Engl J Med 353 (2005) 1224-1235
31. Moser K.L., Gaffney P.M., Grandits M.E., Emamian E.S., Machado D.B., Baechler E.C., et al. The use of microarrays to study autoimmunity. J Investig Dermatol Symp Proc 9 (2004) 18-22
32. Tampoia M., Brescia V., Fontana A., Maggiolini P., Zucano A., and Pansini N. Proteomic: New advances in the diagnosis of rheumatoid arthritis. Clin Chim Acta 357 (2005) 219-225
33. Hueber W., Utz P.J., Steinman L., and Robinson W.H. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res 4 (2002) 290-295
34. Pietropaolo M., and Eisenbach G.S. Autoantibodies in human diabetes. Curr Dir Autoimmun 4 (2001) 252-282
35. Robinson W.H., Garren H., Utz P.J., and Steinman L. Millenium Award, proteome for the development of DNA tolerizing vaccines to treat autoimmune disease. Clin Immunol 103 (2002) 7-12
36. Shoenfeld Y., and Tincani A. Introduction autoantibodies - the smoke and the fire. Autoimmunity 38 (2005) 1-2
37. Check E. Running before we can walk?. Nature 249 (2004) 496-497